Neurocrine Biosciences (NBIX) Return on Sales [ROS] (2009 - 2026)
Neurocrine Biosciences (NBIX) reported Return on Sales [ROS] of 29.51% for Q3 2026, down 0.56 percentage points from 30.07% a year earlier but up 13.71 percentage points from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Return on Sales [ROS] (2009 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Neurocrine Biosciences' Return on Sales [ROS] came in at 23.96%, up 3.46 percentage points year-over-year; for FY2025, it was 21.64%, down 2.58 percentage points from FY2024.
- Return on Sales [ROS] has a five-year change of +6.06 percentage points (FY2020 to FY2025).
- By year, Return on Sales [ROS] came in at 24.22% in FY2024 (+10.93 pp), 13.30% in FY2023 (-3.43 pp), 16.73% in FY2022 (+7.68 pp) and 9.04% in FY2021 (-6.54 pp).
- Five-year quarterly Return on Sales [ROS] spans a low of -27.16% in Q1 2023 and a high of 30.07% in Q3 2025.
- Year over year, Return on Sales [ROS] gained in three of the last eight quarters, with an average year-over-year change of -0.92 percentage points.
- The high point for year-over-year Return on Sales [ROS] in five years was Q1 2024 (a gain of 46.43 percentage points); the low point was Q4 2021 (a drop of 40.60 percentage points).
- Per Business Quant data, the three quarters before Q3 2026 came in at 15.80% (Q2 2026), 23.74% (Q1 2026) and 26.18% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Neurocrine Biosciences | 17.13 Bn | 13.21 Bn | 1.10 Bn | 29.51% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 29.51% |
| Jun 30, 2026 | 15.80% |
| Mar 31, 2026 | 23.74% |
| Dec 31, 2025 | 26.18% |
| Sep 30, 2025 | 30.07% |
| Jun 30, 2025 | 21.18% |
| Mar 31, 2025 | 4.12% |
| Dec 31, 2024 | 22.62% |
| Sep 30, 2024 | 29.55% |
| Jun 30, 2024 | 24.64% |
| Mar 31, 2024 | 19.27% |
| Dec 31, 2023 | 29.17% |
| Sep 30, 2023 | 28.31% |
| Jun 30, 2023 | 16.26% |
| Mar 31, 2023 | -27.16% |
| Dec 31, 2022 | 25.10% |
| Sep 30, 2022 | 22.63% |
| Jun 30, 2022 | 14.46% |
| Mar 31, 2022 | 1.00% |
| Dec 31, 2021 | -11.63% |
API Access
Neurocrine Biosciences Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();